A phase l study of three different dosing schedules of the oral aurora kinase inhibitor MSC1992371A in patients with solid tumors (Q33408947)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase l study of three different dosing schedules of the oral aurora kinase inhibitor MSC1992371A in patients with solid tumors |
scientific article |
Statements
1 reference
A phase l study of three different dosing schedules of the oral aurora kinase inhibitor MSC1992371A in patients with solid tumors (English)
1 reference
M Mita
1 reference
M Gordon
1 reference
N Rejeb
1 reference
A Gianella-Borradori
1 reference
V Jego
1 reference
A Mita
1 reference
J Sarantopoulos
1 reference
K Sankhala
1 reference
D Mendelson
1 reference
6 July 2013
1 reference
1 reference
215-224
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference